Global Secondary Hyperparathyroidism Treatment Market Report 2018 - Industry Analysis, Size, Share, production and Forecasts to 2025

 Buy Now

   Published Date : Sep-2018   |    Format : PDF   |    Pages : 94
Secondary hyperparathyroidism refers to the excessive secretion of parathyroid hormone by the parathyroid glands in response to hypocalcemia and associated hyperplasia of the glands.
In the treatment of secondary hyperparathyroidism due to chronic kidney disease on dialysis calcimimetics do not appear to affect the risk of early death. It does decrease the need for a parathyroidectomy but caused more issues with low blood calcium levels and vomiting.
In 2017, the global Secondary Hyperparathyroidism Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.
This report focuses on the global Secondary Hyperparathyroidism Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Secondary Hyperparathyroidism Treatment development in United States, Europe and China.


The key players covered in this study
    Amgen
    OPKO Health
    AbbVie
    Astellas Pharma
    Roche
    KAI Pharmaceuticals
    Kyowa Hakko Kirin
    Leo Pharma
    Shire
    Sanofi
    Deltanoid Pharmaceuticals

Market segment by Type, the product can be split into
    Surgery
    Drugs
    Vitamin D
    Calcimimetics
    Phosphate Binders

Market segment by Application, split into
    Hospital Pharmacies
    Retail Pharmacies

Market segment by Regions/Countries, this report covers
    United States
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

The study objectives of this report are:
    To analyze global Secondary Hyperparathyroidism Treatment status, future forecast, growth opportunity, key market and key players.
    To present the Secondary Hyperparathyroidism Treatment development in United States, Europe and China.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Secondary Hyperparathyroidism Treatment are as follows:
    History Year: 2013-2017
    Base Year: 2017
    Estimated Year: 2018
    Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

1 Report Overview
    1.1 Study Scope
    1.2 Key Market Segments
    1.3 Players Covered
    1.4 Market Analysis by Type
        1.4.1 Global Secondary Hyperparathyroidism Treatment Market Size Growth Rate by Type (2013-2025)
        1.4.2 Surgery
        1.4.3 Drugs
        1.4.4 Vitamin D
        1.4.5 Calcimimetics
        1.4.6 Phosphate Binders
    1.5 Market by Application
        1.5.1 Global Secondary Hyperparathyroidism Treatment Market Share by Application (2013-2025)
        1.5.2 Hospital Pharmacies
        1.5.3 Retail Pharmacies
    1.6 Study Objectives
    1.7 Years Considered

2 Global Growth Trends
    2.1 Secondary Hyperparathyroidism Treatment Market Size
    2.2 Secondary Hyperparathyroidism Treatment Growth Trends by Regions
        2.2.1 Secondary Hyperparathyroidism Treatment Market Size by Regions (2013-2025)
        2.2.2 Secondary Hyperparathyroidism Treatment Market Share by Regions (2013-2018)
    2.3 Industry Trends
        2.3.1 Market Top Trends
        2.3.2 Market Drivers
        2.3.3 Market Opportunities

3 Market Share by Key Players
    3.1 Secondary Hyperparathyroidism Treatment Market Size by Manufacturers
        3.1.1 Global Secondary Hyperparathyroidism Treatment Revenue by Manufacturers (2013-2018)
        3.1.2 Global Secondary Hyperparathyroidism Treatment Revenue Market Share by Manufacturers (2013-2018)
        3.1.3 Global Secondary Hyperparathyroidism Treatment Market Concentration Ratio (CR5 and HHI)
    3.2 Secondary Hyperparathyroidism Treatment Key Players Head office and Area Served
    3.3 Key Players Secondary Hyperparathyroidism Treatment Product/Solution/Service
    3.4 Date of Enter into Secondary Hyperparathyroidism Treatment Market
    3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
    4.1 Global Secondary Hyperparathyroidism Treatment Market Size by Type (2013-2018)
    4.2 Global Secondary Hyperparathyroidism Treatment Market Size by Application (2013-2018)

5 United States
    5.1 United States Secondary Hyperparathyroidism Treatment Market Size (2013-2018)
    5.2 Secondary Hyperparathyroidism Treatment Key Players in United States
    5.3 United States Secondary Hyperparathyroidism Treatment Market Size by Type
    5.4 United States Secondary Hyperparathyroidism Treatment Market Size by Application

6 Europe
    6.1 Europe Secondary Hyperparathyroidism Treatment Market Size (2013-2018)
    6.2 Secondary Hyperparathyroidism Treatment Key Players in Europe
    6.3 Europe Secondary Hyperparathyroidism Treatment Market Size by Type
    6.4 Europe Secondary Hyperparathyroidism Treatment Market Size by Application

7 China
    7.1 China Secondary Hyperparathyroidism Treatment Market Size (2013-2018)
    7.2 Secondary Hyperparathyroidism Treatment Key Players in China
    7.3 China Secondary Hyperparathyroidism Treatment Market Size by Type
    7.4 China Secondary Hyperparathyroidism Treatment Market Size by Application

8 Japan
    8.1 Japan Secondary Hyperparathyroidism Treatment Market Size (2013-2018)
    8.2 Secondary Hyperparathyroidism Treatment Key Players in Japan
    8.3 Japan Secondary Hyperparathyroidism Treatment Market Size by Type
    8.4 Japan Secondary Hyperparathyroidism Treatment Market Size by Application

9 Southeast Asia
    9.1 Southeast Asia Secondary Hyperparathyroidism Treatment Market Size (2013-2018)
    9.2 Secondary Hyperparathyroidism Treatment Key Players in Southeast Asia
    9.3 Southeast Asia Secondary Hyperparathyroidism Treatment Market Size by Type
    9.4 Southeast Asia Secondary Hyperparathyroidism Treatment Market Size by Application

10 India
    10.1 India Secondary Hyperparathyroidism Treatment Market Size (2013-2018)
    10.2 Secondary Hyperparathyroidism Treatment Key Players in India
    10.3 India Secondary Hyperparathyroidism Treatment Market Size by Type
    10.4 India Secondary Hyperparathyroidism Treatment Market Size by Application

11 Central & South America
    11.1 Central & South America Secondary Hyperparathyroidism Treatment Market Size (2013-2018)
    11.2 Secondary Hyperparathyroidism Treatment Key Players in Central & South America
    11.3 Central & South America Secondary Hyperparathyroidism Treatment Market Size by Type
    11.4 Central & South America Secondary Hyperparathyroidism Treatment Market Size by Application

12 International Players Profiles
    12.1 Amgen
        12.1.1 Amgen Company Details
        12.1.2 Company Description and Business Overview
        12.1.3 Secondary Hyperparathyroidism Treatment Introduction
        12.1.4 Amgen Revenue in Secondary Hyperparathyroidism Treatment Business (2013-2018)
        12.1.5 Amgen Recent Development
    12.2 OPKO Health
        12.2.1 OPKO Health Company Details
        12.2.2 Company Description and Business Overview
        12.2.3 Secondary Hyperparathyroidism Treatment Introduction
        12.2.4 OPKO Health Revenue in Secondary Hyperparathyroidism Treatment Business (2013-2018)
        12.2.5 OPKO Health Recent Development
    12.3 AbbVie
        12.3.1 AbbVie Company Details
        12.3.2 Company Description and Business Overview
        12.3.3 Secondary Hyperparathyroidism Treatment Introduction
        12.3.4 AbbVie Revenue in Secondary Hyperparathyroidism Treatment Business (2013-2018)
        12.3.5 AbbVie Recent Development
    12.4 Astellas Pharma
        12.4.1 Astellas Pharma Company Details
        12.4.2 Company Description and Business Overview
        12.4.3 Secondary Hyperparathyroidism Treatment Introduction
        12.4.4 Astellas Pharma Revenue in Secondary Hyperparathyroidism Treatment Business (2013-2018)
        12.4.5 Astellas Pharma Recent Development
    12.5 Roche
        12.5.1 Roche Company Details
        12.5.2 Company Description and Business Overview
        12.5.3 Secondary Hyperparathyroidism Treatment Introduction
        12.5.4 Roche Revenue in Secondary Hyperparathyroidism Treatment Business (2013-2018)
        12.5.5 Roche Recent Development
    12.6 KAI Pharmaceuticals
        12.6.1 KAI Pharmaceuticals Company Details
        12.6.2 Company Description and Business Overview
        12.6.3 Secondary Hyperparathyroidism Treatment Introduction
        12.6.4 KAI Pharmaceuticals Revenue in Secondary Hyperparathyroidism Treatment Business (2013-2018)
        12.6.5 KAI Pharmaceuticals Recent Development
    12.7 Kyowa Hakko Kirin
        12.7.1 Kyowa Hakko Kirin Company Details
        12.7.2 Company Description and Business Overview
        12.7.3 Secondary Hyperparathyroidism Treatment Introduction
        12.7.4 Kyowa Hakko Kirin Revenue in Secondary Hyperparathyroidism Treatment Business (2013-2018)
        12.7.5 Kyowa Hakko Kirin Recent Development
    12.8 Leo Pharma
        12.8.1 Leo Pharma Company Details
        12.8.2 Company Description and Business Overview
        12.8.3 Secondary Hyperparathyroidism Treatment Introduction
        12.8.4 Leo Pharma Revenue in Secondary Hyperparathyroidism Treatment Business (2013-2018)
        12.8.5 Leo Pharma Recent Development
    12.9 Shire
        12.9.1 Shire Company Details
        12.9.2 Company Description and Business Overview
        12.9.3 Secondary Hyperparathyroidism Treatment Introduction
        12.9.4 Shire Revenue in Secondary Hyperparathyroidism Treatment Business (2013-2018)
        12.9.5 Shire Recent Development
    12.10 Sanofi
        12.10.1 Sanofi Company Details
        12.10.2 Company Description and Business Overview
        12.10.3 Secondary Hyperparathyroidism Treatment Introduction
        12.10.4 Sanofi Revenue in Secondary Hyperparathyroidism Treatment Business (2013-2018)
        12.10.5 Sanofi Recent Development
    12.11 Deltanoid Pharmaceuticals

13 Market Forecast 2018-2025
    13.1 Market Size Forecast by Regions
    13.2 United States
    13.3 Europe
    13.4 China
    13.5 Japan
    13.6 Southeast Asia
    13.7 India
    13.8 Central & South America
    13.9 Market Size Forecast by Product (2018-2025)
    13.10 Market Size Forecast by Application (2018-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
            15.1.1.1 Research Programs/Design
            15.1.1.2 Market Size Estimation
            12.1.1.3 Market Breakdown and Data Triangulation
        15.1.2 Data Source
            15.1.2.1 Secondary Sources
            15.1.2.2 Primary Sources
    15.2 Disclaimer
    15.3 Author Details



List of Tables and Figures

    Table Secondary Hyperparathyroidism Treatment Key Market Segments
    Table Key Players Secondary Hyperparathyroidism Treatment Covered
    Table Global Secondary Hyperparathyroidism Treatment Market Size Growth Rate by Type 2013-2025 (Million US$)
    Figure Global Secondary Hyperparathyroidism Treatment Market Size Market Share by Type 2013-2025
    Figure Surgery Figures
    Table Key Players of Surgery
    Figure Drugs Figures
    Table Key Players of Drugs
    Figure Vitamin D Figures
    Table Key Players of Vitamin D
    Figure Calcimimetics Figures
    Table Key Players of Calcimimetics
    Figure Phosphate Binders Figures
    Table Key Players of Phosphate Binders
    Table Global Secondary Hyperparathyroidism Treatment Market Size Growth by Application 2013-2025 (Million US$)
    Figure Hospital Pharmacies Case Studies
    Figure Retail Pharmacies Case Studies
    Figure Secondary Hyperparathyroidism Treatment Report Years Considered
    Table Global Secondary Hyperparathyroidism Treatment Market Size 2013-2025 (Million US$)
    Figure Global Secondary Hyperparathyroidism Treatment Market Size and Growth Rate 2013-2025 (Million US$)
    Table Global Secondary Hyperparathyroidism Treatment Market Size by Regions 2013-2025 (Million US$)
    Table Global Secondary Hyperparathyroidism Treatment Market Size by Regions 2013-2018 (Million US$)
    Table Global Secondary Hyperparathyroidism Treatment Market Share by Regions 2013-2018
    Figure Global Secondary Hyperparathyroidism Treatment Market Share by Regions 2013-2018
    Figure Global Secondary Hyperparathyroidism Treatment Market Share by Regions 2018
    Table Market Top Trends
    Table Global Secondary Hyperparathyroidism Treatment Revenue by Manufacturers (2013-2018) (Million US$)
    Table Global Secondary Hyperparathyroidism Treatment Market Share by Manufacturers (2013-2018)
    Figure Global Secondary Hyperparathyroidism Treatment Market Share by Manufacturers in 2018
    Table Global Secondary Hyperparathyroidism Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Key Players Head office and Area Served
    Table Key Players Secondary Hyperparathyroidism Treatment Product/Solution/Service
    Table Date of Enter into Secondary Hyperparathyroidism Treatment Market
    Table Mergers & Acquisitions, Expansion Plans
    Table Global Secondary Hyperparathyroidism Treatment Market Size by Type (2013-2018) (Million US$)
    Table Global Secondary Hyperparathyroidism Treatment Market Size Share by Type (2013-2018)
    Figure Global Secondary Hyperparathyroidism Treatment Market Size Market Share by Type (2013-2018)
    Table Global Secondary Hyperparathyroidism Treatment Market Size by Application (2013-2018) (Million US$)
    Table Global Secondary Hyperparathyroidism Treatment Market Size Share by Application (2013-2018)
    Figure Global Secondary Hyperparathyroidism Treatment Market Size Market Share by Application (2013-2018)
    Figure Global Secondary Hyperparathyroidism Treatment Revenue Market Share by Application in 2017
    Figure United States Secondary Hyperparathyroidism Treatment Market Size 2013-2018 (Million US$)
    Table United States Key Players Secondary Hyperparathyroidism Treatment Revenue (2017-2018) (Million US$)
    Table United States Key Players Secondary Hyperparathyroidism Treatment Market Share (2017-2018)
    Table United States Secondary Hyperparathyroidism Treatment Market Size by Type (2013-2018) (Million US$)
    Table United States Secondary Hyperparathyroidism Treatment Market Share by Type (2013-2018)
    Table United States Secondary Hyperparathyroidism Treatment Market Size by Application (2013-2018) (Million US$)
    Table United States Secondary Hyperparathyroidism Treatment Market Share by Application (2013-2018)
    Figure Europe Secondary Hyperparathyroidism Treatment Market Size 2013-2018 (Million US$)
    Table Europe Key Players Secondary Hyperparathyroidism Treatment Revenue (2017-2018) (Million US$)
    Table Europe Key Players Secondary Hyperparathyroidism Treatment Market Share (2017-2018)
    Table Europe Secondary Hyperparathyroidism Treatment Market Size by Type (2013-2018) (Million US$)
    Table Europe Secondary Hyperparathyroidism Treatment Market Share by Type (2013-2018)
    Table Europe Secondary Hyperparathyroidism Treatment Market Size by Application (2013-2018) (Million US$)
    Table Europe Secondary Hyperparathyroidism Treatment Market Share by Application (2013-2018)
    Figure China Secondary Hyperparathyroidism Treatment Market Size 2013-2018 (Million US$)
    Table China Key Players Secondary Hyperparathyroidism Treatment Revenue (2017-2018) (Million US$)
    Table China Key Players Secondary Hyperparathyroidism Treatment Market Share (2017-2018)
    Table China Secondary Hyperparathyroidism Treatment Market Size by Type (2013-2018) (Million US$)
    Table China Secondary Hyperparathyroidism Treatment Market Share by Type (2013-2018)
    Table China Secondary Hyperparathyroidism Treatment Market Size by Application (2013-2018) (Million US$)
    Table China Secondary Hyperparathyroidism Treatment Market Share by Application (2013-2018)
    Figure Japan Secondary Hyperparathyroidism Treatment Market Size 2013-2018 (Million US$)
    Table Japan Key Players Secondary Hyperparathyroidism Treatment Revenue (2017-2018) (Million US$)
    Table Japan Key Players Secondary Hyperparathyroidism Treatment Market Share (2017-2018)
    Table Japan Secondary Hyperparathyroidism Treatment Market Size by Type (2013-2018) (Million US$)
    Table Japan Secondary Hyperparathyroidism Treatment Market Share by Type (2013-2018)
    Table Japan Secondary Hyperparathyroidism Treatment Market Size by Application (2013-2018) (Million US$)
    Table Japan Secondary Hyperparathyroidism Treatment Market Share by Application (2013-2018)
    Figure Southeast Asia Secondary Hyperparathyroidism Treatment Market Size 2013-2018 (Million US$)
    Table Southeast Asia Key Players Secondary Hyperparathyroidism Treatment Revenue (2017-2018) (Million US$)
    Table Southeast Asia Key Players Secondary Hyperparathyroidism Treatment Market Share (2017-2018)
    Table Southeast Asia Secondary Hyperparathyroidism Treatment Market Size by Type (2013-2018) (Million US$)
    Table Southeast Asia Secondary Hyperparathyroidism Treatment Market Share by Type (2013-2018)
    Table Southeast Asia Secondary Hyperparathyroidism Treatment Market Size by Application (2013-2018) (Million US$)
    Table Southeast Asia Secondary Hyperparathyroidism Treatment Market Share by Application (2013-2018)
    Figure India Secondary Hyperparathyroidism Treatment Market Size 2013-2018 (Million US$)
    Table India Key Players Secondary Hyperparathyroidism Treatment Revenue (2017-2018) (Million US$)
    Table India Key Players Secondary Hyperparathyroidism Treatment Market Share (2017-2018)
    Table India Secondary Hyperparathyroidism Treatment Market Size by Type (2013-2018) (Million US$)
    Table India Secondary Hyperparathyroidism Treatment Market Share by Type (2013-2018)
    Table India Secondary Hyperparathyroidism Treatment Market Size by Application (2013-2018) (Million US$)
    Table India Secondary Hyperparathyroidism Treatment Market Share by Application (2013-2018)
    Figure Central & South America Secondary Hyperparathyroidism Treatment Market Size 2013-2018 (Million US$)
    Table Central & South America Key Players Secondary Hyperparathyroidism Treatment Revenue (2017-2018) (Million US$)
    Table Central & South America Key Players Secondary Hyperparathyroidism Treatment Market Share (2017-2018)
    Table Central & South America Secondary Hyperparathyroidism Treatment Market Size by Type (2013-2018) (Million US$)
    Table Central & South America Secondary Hyperparathyroidism Treatment Market Share by Type (2013-2018)
    Table Central & South America Secondary Hyperparathyroidism Treatment Market Size by Application (2013-2018) (Million US$)
    Table Central & South America Secondary Hyperparathyroidism Treatment Market Share by Application (2013-2018)
    Table Amgen Company Details
    Table Amgen Revenue in Secondary Hyperparathyroidism Treatment Business (2013-2018) (Million US$)
    Figure Amgen Revenue Growth Rate in Secondary Hyperparathyroidism Treatment Business (2013-2018)
    Table Amgen Recent Development
    Table OPKO Health Company Details
    Table OPKO Health Revenue in Secondary Hyperparathyroidism Treatment Business (2013-2018)(Million US$)
    Figure OPKO Health Revenue Growth Rate in Secondary Hyperparathyroidism Treatment Business (2013-2018)
    Table OPKO Health Recent Development
    Table AbbVie Company Details
    Table AbbVie Revenue in Secondary Hyperparathyroidism Treatment Business (2013-2018)(Million US$)
    Figure AbbVie Revenue Growth Rate in Secondary Hyperparathyroidism Treatment Business (2013-2018)
    Table AbbVie Recent Development
    Table Astellas Pharma Company Details
    Table Astellas Pharma Revenue in Secondary Hyperparathyroidism Treatment Business (2013-2018)(Million US$)
    Figure Astellas Pharma Revenue Growth Rate in Secondary Hyperparathyroidism Treatment Business (2013-2018)
    Table Astellas Pharma Recent Development
    Table Roche Company Details
    Table Roche Revenue in Secondary Hyperparathyroidism Treatment Business (2013-2018)(Million US$)
    Figure Roche Revenue Growth Rate in Secondary Hyperparathyroidism Treatment Business (2013-2018)
    Table Roche Recent Development
    Table KAI Pharmaceuticals Company Details
    Table KAI Pharmaceuticals Revenue in Secondary Hyperparathyroidism Treatment Business (2013-2018)(Million US$)
    Figure KAI Pharmaceuticals Revenue Growth Rate in Secondary Hyperparathyroidism Treatment Business (2013-2018)
    Table KAI Pharmaceuticals Recent Development
    Table Kyowa Hakko Kirin Company Details
    Table Kyowa Hakko Kirin Revenue in Secondary Hyperparathyroidism Treatment Business (2013-2018)(Million US$)
    Figure Kyowa Hakko Kirin Revenue Growth Rate in Secondary Hyperparathyroidism Treatment Business (2013-2018)
    Table Kyowa Hakko Kirin Recent Development
    Table Leo Pharma Company Details
    Table Leo Pharma Revenue in Secondary Hyperparathyroidism Treatment Business (2013-2018)(Million US$)
    Figure Leo Pharma Revenue Growth Rate in Secondary Hyperparathyroidism Treatment Business (2013-2018)
    Table Leo Pharma Recent Development
    Table Shire Company Details
    Table Shire Revenue in Secondary Hyperparathyroidism Treatment Business (2013-2018)(Million US$)
    Figure Shire Revenue Growth Rate in Secondary Hyperparathyroidism Treatment Business (2013-2018)
    Table Shire Recent Development
    Table Sanofi Company Details
    Table Sanofi Revenue in Secondary Hyperparathyroidism Treatment Business (2013-2018)(Million US$)
    Figure Sanofi Revenue Growth Rate in Secondary Hyperparathyroidism Treatment Business (2013-2018)
    Table Sanofi Recent Development
    Table Deltanoid Pharmaceuticals Company Details
    Table Global Secondary Hyperparathyroidism Treatment Market Size by Regions (Million US$) 2018-2025
    Figure Global Secondary Hyperparathyroidism Treatment Market Size Share by Regions (2018-2025)
    Figure Global Secondary Hyperparathyroidism Treatment Market Size Share by Regions in 2025
    Figure United States Secondary Hyperparathyroidism Treatment Market Size Forecast (2018-2025)(Million USD)
    Figure Europe Secondary Hyperparathyroidism Treatment Market Size Forecast (2018-2025)(Million USD)
    Figure China Secondary Hyperparathyroidism Treatment Market Size Forecast (2018-2025)(Million USD)
    Figure Japan Secondary Hyperparathyroidism Treatment Market Size Forecast (2018-2025)(Million USD)
    Figure Southeast Asia Secondary Hyperparathyroidism Treatment Market Size Forecast (2018-2025)(Million USD)
    Figure India Secondary Hyperparathyroidism Treatment Market Size Forecast (2018-2025)(Million USD)
    Figure Central & South America Secondary Hyperparathyroidism Treatment Market Size Forecast (2018-2025)(Million USD)
    Table Global Secondary Hyperparathyroidism Treatment Market Size by Product (2018-2025) (Million US$)
    Figure Global Secondary Hyperparathyroidism Treatment Market Size by Product (2018-2025)
    Figure Global Secondary Hyperparathyroidism Treatment Market Size by Product in 2025
    Table Global Secondary Hyperparathyroidism Treatment Market Size by Application (2018-2025) (Million US$)
    Figure Global Secondary Hyperparathyroidism Treatment Market Size by Application (2018-2025)
    Figure Global Secondary Hyperparathyroidism Treatment Market Size by Application in 2025
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources

Latest News

25-Feb-2019 | Chemicals & Materials

Industrial Alliance To Help Waste Management Market To Rise

An alliance of 28 large companies has launched a global organization to find solutions to remove plastic waste from the environment. The Alliance for the Disposal of Plastic Waste (AEPW), which collaborates with the World Business Council for Sustainable Development (WBCSD), brings together chemical and plastic companies as well as consumer goods companies.

25-Feb-2019 | Electrical & Electronic Device

Insights Into Fish’s Swimming Adds Sensory Feedback Feature To Global Robotics Market

The fish have a random movement with excellent sensory feedback so as to help them navigate the world. According to the Johns Hopkins University researchers, the inclusion of this movement in understanding the active sensing behaviors of animals can actually help advance the robotic platform in terms of medical, industrial, defense, and commercial sectors. The sensors can help improve the inter ...

13-Feb-2019 | Technology

Battle Between Apple And Qualcomm Likely To Impact The Growth Of The Smartphone Market

The smartphone market has observed a tremendous transformation owing to advancement in technology, better services, the advent of 4G & 5G networks, and so on. Recently, Qualcomm Inc had filed a patent lawsuit against Apple Inc that imposed a veto on sales of few iPhone devices in Germany. This, certainly, was expected to pose a negative impact on the growth of the smartphone market in that ...

13-Feb-2019 | Food & Beverage

Belizean Turmeric Gets Place in Global Turmeric Market

A novel product manufactured from Belizean-grown turmeric has started to hit the shelves of grocery stores in Belize as well as in Canada. The latest product is supposed to catch the turmeric market in the rest of the Caribbean as well. This budge is supposed to offer novel opportunities to farmers as well as agro-processors in the Toledo district. Till date, more than 350 turmeric cultivators ...

05-Feb-2019 | Automobile

Automotive Mobility Market Growth Has A Handle On New AEye Product Sale

The automotive mobility market will be skyrocketing by this year as AEye, which is one of the world’s best artificial perception systems and the maker of iDAR has recently declared that it will be launching the AE110. The new technology has been built on the highly wide-ranging solid-state LiDAR patent portfolio. The AE110 is the only one possessing the firm's solitary software-linked ...